DWA
VYGR icon

Dorsey Wright & Associates’s Voyager Therapeutics VYGR Stock Holding History

Dorsey Wright & Associates’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,800
Closed -$32.1K – 332
2023
Q2 		$32.1K Buy
2,800
+279
+11% +$2.89K 0.01% 171
2023
Q1 		$19.4K Buy
+2,521
New +$20K 0.01% 242

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dorsey Wright & Associates's VYGR Position: Q3 2023 in Review

Dorsey Wright & Associates sold out of Voyager Therapeutics (VYGR) in Q3 2023, closing a stake of 2,800 shares — an estimated $32.1K sold.

Dorsey Wright & Associates first reported a position in VYGR in Q1 2023 and held it in 2 quarters. The position peaked at $32.1K in Q2 2023. 110 funds tracked by Wall St. Rank hold VYGR as of Q3 2023.

  • Dorsey Wright & Associates reported no remaining Voyager Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 2,800 Voyager Therapeutics shares in Q3 2023, an estimated $32.1K.
  • Dorsey Wright & Associates first reported a position in Voyager Therapeutics in Q1 2023 and held it in 2 quarters.
  • Dorsey Wright & Associates's Voyager Therapeutics position peaked at $32.1K in Q2 2023.
  • 110 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2023.

Based on Dorsey Wright & Associates's 13F filing for Q3 2023, filed 7 Nov 2023.